Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest.
Spirito A, Vaisnora L, Papadis A, Iacovelli F, Sardu C, Selberg A, Bär S, Kavaliauskaite R, Temperli F, Asatryan B, Pilgrim T, Hunziker L, Heg D, Valgimigli M, Windecker S, Räber L. Spirito A, et al. Among authors: temperli f. J Am Coll Cardiol. 2023 Feb 7;81(5):446-456. doi: 10.1016/j.jacc.2022.10.039. J Am Coll Cardiol. 2023. PMID: 36725173 Free article.
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
Koskinas KC, Zanchin T, Klingenberg R, Gencer B, Temperli F, Baumbach A, Roffi M, Moschovitis A, Muller O, Tüller D, Stortecky S, Mach F, Lüscher TF, Matter CM, Pilgrim T, Heg D, Windecker S, Räber L. Koskinas KC, et al. Among authors: temperli f. J Am Heart Assoc. 2018 Apr 13;7(8):e008085. doi: 10.1161/JAHA.117.008085. J Am Heart Assoc. 2018. PMID: 29654204 Free PMC article. Clinical Trial.
Frequency, Reasons, and Impact of Premature Ticagrelor Discontinuation in Patients Undergoing Coronary Revascularization in Routine Clinical Practice: Results From the Bern Percutaneous Coronary Intervention Registry.
Zanchin T, Temperli F, Karagiannis A, Zanchin C, Räsänen M, Koskinas KC, Stortecky S, Hunziker L, Praz F, Blöchlinger S, Moro C, Moschovitis A, Seiler C, Billinger M, Heg D, Pilgrim T, Valgimigli M, Windecker S, Räber L. Zanchin T, et al. Among authors: temperli f. Circ Cardiovasc Interv. 2018 May;11(5):e006132. doi: 10.1161/CIRCINTERVENTIONS.117.006132. Circ Cardiovasc Interv. 2018. PMID: 29748219
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest.
Spirito A, Papadis A, Vaisnora L, Iacovelli F, Sardu C, Kavaliauskaite R, Lanz J, Temperli F, Asatryan B, Heg D, Hunziker L, Windecker S, Räber L, Valgimigli M. Spirito A, et al. Among authors: temperli f. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1338-1348. doi: 10.1016/j.jcin.2022.04.024. Epub 2022 Jun 15. JACC Cardiovasc Interv. 2022. PMID: 35798477 Free article.
Clinical outcomes in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary interventions later than 48 h after symptom onset.
Rohla M, Temperli F, Siontis GCM, Klingenberg R, Gencer B, Rodondi N, Bär S, Nanchen D, Mach F, Häner JD, Pilgrim T, Muller O, Matter CM, Lüscher T, Roffi M, Heg D, Windecker S, Räber L. Rohla M, et al. Among authors: temperli f. Eur Heart J Acute Cardiovasc Care. 2023 Jun 2;12(6):376-385. doi: 10.1093/ehjacc/zuad033. Eur Heart J Acute Cardiovasc Care. 2023. PMID: 36996409 Free article.
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial.
Bär S, Kavaliauskaite R, Otsuka T, Ueki Y, Häner JD, Siontis GCM, Stortecky S, Shibutani H, Temperli F, Kaiser C, Iglesias JF, Jan van Geuns R, Daemen J, Spirk D, Engstrøm T, Lang I, Windecker S, Koskinas KC, Losdat S, Räber L. Bär S, et al. Among authors: temperli f. EuroIntervention. 2023 Jul 17;19(4):e286-e296. doi: 10.4244/EIJ-D-23-00201. EuroIntervention. 2023. PMID: 37341586 Free article. Clinical Trial.
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
Ueki Y, Häner JD, Losdat S, Gargiulo G, Shibutani H, Bär S, Otsuka T, Kavaliauskaite R, Mitter VR, Temperli F, Spirk D, Stortecky S, Siontis GCM, Valgimigli M, Windecker S, Gutmann C, Koskinas KC, Mayr M, Räber L. Ueki Y, et al. Among authors: temperli f. Thromb Haemost. 2024 Jun;124(6):517-527. doi: 10.1055/a-2156-7872. Epub 2023 Aug 18. Thromb Haemost. 2024. PMID: 37595625 Clinical Trial.
Computed Tomography Scan Evidence for Left Atrial Appendage Short-Term Remodeling Following Percutaneous Occlusion: Impact of Device Oversizing.
Mahmoudi K, Galea R, Elhadad S, Temperli F, Sebag F, Gräni C, Rezine Z, Roten L, Landolff Q, Brugger N, Masri A, Räber L, Amabile N. Mahmoudi K, et al. Among authors: temperli f. J Am Heart Assoc. 2023 Sep 5;12(17):e030037. doi: 10.1161/JAHA.123.030037. Epub 2023 Aug 23. J Am Heart Assoc. 2023. PMID: 37609989 Free PMC article.
Pretreatment With P2Y12 Inhibitors in ST-Segment Elevation Myocardial Infarction: Insights From the Bern-PCI Registry.
Rohla M, Ye SX, Shibutani H, Bruno J, Otsuka T, Häner JD, Bär S, Temperli F, Kavaliauskaite R, Lanz J, Stortecky S, Praz F, Hunziker L, Pilgrim T, Siontis GC, Losdat S, Windecker S, Räber L. Rohla M, et al. Among authors: temperli f. JACC Cardiovasc Interv. 2024 Jan 8;17(1):17-28. doi: 10.1016/j.jcin.2023.10.064. JACC Cardiovasc Interv. 2024. PMID: 38199749
12 results